Johnson & Johnson (NYSE:JNJ) has lost its challenge to a $302 million judgment over its marketing of pelvic mesh products. The U.S. Supreme Court refused to hear J&J's appeal, leaving the...
![JNJ Takes a Hit: Loses $302M Judgment Over Pelvic Mesh Marketing!](https://legalfavor.com/wp-content/uploads/2023/02/Twitter-Article-Images-5-1080x675.png)
Johnson & Johnson (NYSE:JNJ) has lost its challenge to a $302 million judgment over its marketing of pelvic mesh products. The U.S. Supreme Court refused to hear J&J's appeal, leaving the...